Shares of several companies including Bharat Electronics, Piramal Pharma, Hindustan Aeronautics, and Aditya Birla Real Estate ...

The abrupt resignation announcement that came late on Friday, March 28, from Peter Marks, who heads the U.S. FDA's Center for ...

Piramal believes that while passing the baton of the group's business, it is crucial for leaders—especially those accustomed ...

In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

GIFT Nifty was trading lower at 23,502, which indicates a negative start for domestic indices. Here are the top stocks to ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

Nandini Piramal says the CDMO business, which contributed 58% of revenues in FY24, aspires to grow as a $1.2 billion business with a 25% EBITDA margin by 2030 ...

Pharmaceutical companies are increasingly outsourcing their manufacturing processes to CDMOs to focus on core competencies such as research and development Based on end use, the pharmaceutical ...

[TOKYO] Bank of Japan (BOJ) governor Kazuo Ueda indicated he’s not too concerned about the country’s government bond yields ascending to the highest level since 2008, signalling he’s not planning any ...